Literature DB >> 26837849

Bioethics meets Ebola: exploring the moral landscape.

Alison K Thompson1.   

Abstract

INTRODUCTION: The Ebola Virus Disease (EVD) outbreak in West Africa raised ethical issues about structural disadvantage; the duty to care of healthcare workers; the use and study of unregistered agents; the use of restrictive measures like mass quarantine and the importance of public trust. SOURCES OF DATA: WHO reports, literature on EVD and ethics. AREAS OF AGREEMENT: The use of restrictive measures and the testing of unregistered agents is ethical if support for individuals or communities is provided. AREAS OF CONTROVERSY: Controversy exists over ethical trial design for the study of unregistered agents and over the limits of the duty to care. GROWING POINTS: The role of the WHO in outbreak control and research oversight needs rethinking and further support. Solidarity in global health needs fostering. AREAS TIMELY FOR DEVELOPING RESEARCH: Research is needed on how to restore and enhance health systems and public trust in EVD-affected countries.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ebola; duty to care; ethics; global solidarity; public health ethics; public trust; research in public health emergencies; restrictive measures

Mesh:

Year:  2016        PMID: 26837849     DOI: 10.1093/bmb/ldv055

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  2 in total

1.  Research Ethics Committees (RECs) and epidemic response in low and middle income countries.

Authors:  Luchuo Engelbert Bain; Chia Gerald Ngwain; Julius Nwobegahay; Jeffery Gabriel Sumboh; Rogers Nditanchou; Paschal Kum Awah
Journal:  Pan Afr Med J       Date:  2018-11-28

2.  Lessons From Italy's and Sweden's Policies in Fighting COVID-19: The Contribution of Biomedical and Social Competences.

Authors:  Mirko Farina; Andrea Lavazza
Journal:  Front Public Health       Date:  2020-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.